Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-12 Sale | 2021-11-16 7:57 pm | Jounce Therapeutics Inc. | JNCE | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner | 1,900,000 | $8.38 | $15,922,000 | 4,698,661 (Indirect Direct) | View |
| 2021-06-16 Purchase | 2021-06-17 09:15 am | Sage Therapeutics Inc. | SAGE | STARR KEVIN P Director | 17,842 | $56.05 | $999,983 | 320,659 (Direct) | View |
| 2021-06-03 Sale | 2021-06-07 6:10 pm | Revolution Medicines Inc. | RVMD | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner | 543,113 | $30.21 | $16,406,962 | 5,911,804 (Indirect Direct) | View |
| 2021-05-25 Sale | 2021-05-27 5:43 pm | Revolution Medicines Inc. | RVMD | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner | 1,366,204 | $30.57 | $41,764,208 | 6,454,917 (Indirect Direct) | View |
| 2021-05-25 Sale | 2021-05-27 5:42 pm | Jounce Therapeutics Inc. | JNCE | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner | 552,520 | $8 | $4,420,160 | 9,387,176 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-15 Option Award | 2023-06-16 4:05 pm | N/A 2033-06-15 | Sage Therapeutics Inc. | SAGE | STARR KEVIN P Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 4:35 pm | N/A 2032-06-16 | Sage Therapeutics Inc. | SAGE | STARR KEVIN P Director | 9,947 | $0 | 9,947 (Direct) | View |
| 2021-11-10 Other | 2021-11-12 5:26 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC STARR KEVIN P TEPPER ROBERT I 10% Owner | 1,000,000 | $0 | 7,473,794 (Direct) | View |
| 2021-09-22 Other | 2021-09-24 4:13 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC STARR KEVIN P TEPPER ROBERT I 10% Owner | 1,000,000 | $0 | 8,389,054 (Direct) | View |
| 2021-09-15 Other | 2021-09-17 4:15 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner | 1,750,000 | $0 | 8,348,661 (Direct) | View |
| 2021-06-10 Other | 2021-06-14 4:19 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner | 1,500,000 | $0 | 9,647,049 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-11 4:07 pm | N/A 2031-06-10 | Sage Therapeutics Inc. | SAGE | STARR KEVIN P Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-05-06 Other | 2021-05-10 4:41 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner | 1,085,784 | $0 | 4,768,725 (Direct) | View |